Get the Stockscreener App
2.36
0.00%
0.00
After Hours:
2.38
0.02
+0.85%
Alzamend Neuro Inc stock is traded at $2.36, with a volume of 34,900.
It is up +0.00% in the last 24 hours and up +8.26% over the past month.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.
See More
Previous Close:
$2.36
Open:
$2.37
24h Volume:
34,900
Relative Volume:
0.31
Market Cap:
$7.41M
Revenue:
-
Net Income/Loss:
$-6.24M
P/E Ratio:
-0.4225
EPS:
-5.5853
Net Cash Flow:
$-8.09M
1W Performance:
-5.98%
1M Performance:
+8.26%
6M Performance:
-60.15%
1Y Performance:
-82.52%
1-Day Range:
$2.32
$2.38
1-Week Range:
$2.31
$2.6099
52-Week Range:
$2.06
$14.31
Alzamend Neuro Inc Stock (ALZN) Company Profile
Name
Alzamend Neuro Inc
Sector
Industry
Phone
844-722-6333
Address
3500 LENOX RD. NE, ATLANTA
Compare ALZN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
2.36 | 8.97M | 0 | -6.24M | -8.09M | -5.5853 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.22 | 106.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
674.55 | 68.81B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.95 | 58.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
889.64 | 53.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
193.69 | 40.93B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-21 | Initiated | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc Stock (ALZN) Latest News
What analyst consensus says on Alzamend Neuro Inc. stockPortfolio Risk Report & Fast Exit Strategy with Risk Control - newser.com
Can Alzamend Neuro Inc. stock outperform in 2025 bull marketDay Trade & Community Consensus Trade Alerts - newser.com
Multi asset correlation models including Alzamend Neuro Inc.Portfolio Risk Summary & Entry and Exit Point Strategies - newser.com
What earnings revisions data tells us about Alzamend Neuro Inc.July 2025 PreEarnings & Scalable Portfolio Growth Ideas - newser.com
Will Alzamend Neuro Inc. stock remain a Wall Street favoriteAnalyst Upgrade & Proven Capital Preservation Tips - newser.com
How Alzamend Neuro Inc. stock reacts to job market dataJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com
Alzamend Neuro Inc. stock trend outlook and recovery pathJuly 2025 Institutional & Weekly Stock Performance Updates - newser.com
Is Alzamend Neuro Inc. stock supported by innovation pipeline2025 Trade Ideas & Expert Verified Stock Movement Alerts - newser.com
Will Alzamend Neuro Inc. stock go up soonQuarterly Trade Review & Free Daily Entry Point Trade Alerts - newser.com
Will Alzamend Neuro Inc. stock reach all time highs in 2025 - newser.com
Comparing Alzamend Neuro Inc. in custom built stock radars2025 Top Decliners & Fast Gain Swing Trade Alerts - newser.com
How to build a dashboard for Alzamend Neuro Inc. stock2025 Volume Leaders & Free High Return Stock Watch Alerts - newser.com
What to do if you’re stuck in Alzamend Neuro Inc.Weekly Profit Recap & AI Driven Price Predictions - newser.com
Published on: 2025-11-09 13:05:24 - newser.com
Chart based exit strategy for Alzamend Neuro Inc.Portfolio Performance Report & Long-Term Investment Growth Plans - newser.com
Is Alzamend Neuro Inc. stock recession proofPortfolio Gains Report & Safe Entry Zone Identification - newser.com
Historical volatility pattern of Alzamend Neuro Inc. visualizedFed Meeting & AI Powered Buy and Sell Recommendations - newser.com
Is Alzamend Neuro Inc. stock a buy before product launchesInsider Selling & Weekly Watchlist for Hot Stocks - Fundação Cultural do Pará
Predicting Alzamend Neuro Inc. trend using moving averages2025 Technical Overview & Smart Investment Allocation Insights - newser.com
Will Alzamend Neuro Inc. stock rally after Fed decisions2025 Major Catalysts & Real-Time Price Movement Reports - newser.com
How rising interest rates impact Alzamend Neuro Inc. stockPortfolio Performance Report & Low Drawdown Momentum Ideas - fcp.pa.gov.br
Published on: 2025-11-05 05:06:55 - newser.com
Is Alzamend Neuro Inc. forming a bottoming basePortfolio Gains Summary & Free Community Supported Trade Ideas - newser.com
How currency fluctuations impact Alzamend Neuro Inc. stock2025 AllTime Highs & Safe Entry Point Alerts - newser.com
Can Alzamend Neuro Inc. stock resist sector downturnsJuly 2025 Earnings & Reliable Volume Spike Alerts - newser.com
Published on: 2025-11-04 07:10:34 - newser.com
Alzamend Neuro Inc Stock (ALZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):